Angiotensin-Converting enzyme gene polymorphism significantly affects renal posttransplantation erythrocytosis
- 1 January 2004
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 36 (1) , 161-163
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosisAmerican Journal of Kidney Diseases, 2002
- COMPARISON OF THE EFFECTS OF ENALAPRIL AND LOSARTAN ON POSTTRANSPLANTATION ERYTHROCYTOSIS IN RENAL TRANSPLANT RECIPIENTSTransplantation, 2001
- Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal diseaseKidney International, 2001
- The effect of losartan on posttransplant erythrocytosisTransplantation Proceedings, 2001
- Angiotensin II increases erythropoietin production in healthy human volunteersEuropean Journal of Clinical Investigation, 1999
- Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosisTransplantation Proceedings, 1999
- EFFECTS OF ERYTHROPOIETIN, ANGIOTENSIN II, AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR ON ERYTHROID PRECURSORS IN PATIENTS WITH POSTTRANSPLANTATION ERYTHROCYTOSISTransplantation, 1999
- Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patientsNephrology Dialysis Transplantation, 1998
- Posttransplant erythrocytosis: A possible nonerythropoietin-mediated mechanismTransplantation Proceedings, 1997
- ANGIOTENSIN-CONVERTING ENZYME INHIBITION IN THE TREATMENT OF RENAL TRANSPLANT ERYTHROCYTOSIS CLINICAL EXPERIENCE AND OBSERVATION OF MECHANISMTransplantation, 1995